Diagnosis of Inflammatory Bowel Disease

* To quantify the expression of Nuclear enriched abundant transcript 1 (NEAT1) and Anti-sense Non RNA in the INLK4 locus (ANRIL) to determine their potential role as non invasive diagnostic biomarkers in inflammatory bowel disease. * To evaluate the correlation between the studied biomarkers and both the clinical presentation of the patients and the inflammatory mediators like Nuclear factor κB (NF-KB) signaling pathway.

NCT Number	NCT07400211
Lead Sponsor	Assiut University
Conditions	Inflammatory Bowel Disease (IBD)
Enrollment	62 participants
Start Date	2026-04-01
Primary Completion	2028-04-01 (estimated)
Study Completion	2028-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-11